Related Experiment Video
Updated: Aug 19, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes
T Kudoh1, T Ishidate, M Moriyama
1Department of Oncogene Research, Osaka University, Japan.
Abstract:
WT1, the Wilms tumor-suppressor gene, maps to the human chromosomal region 11p13 and encodes a transcriptional repressor, WT1, implicated in controlling normal urogenital development. Microinjection of the WT1 cDNA into quiescent cells or cells in early to mid G1 phase blocked serum-induced cell cycle progression into S phase. The activity of WT1 varied significantly depending on the presence or absence of an alternatively spliced region located upstream of the zinc finger domain. The inhibitory activity of WT1 was abrogated by the overexpression of cyclin E/CDK2 as well as cyclin D1/CDK4. Furthermore, both CDK4- and CDK2-associated kinase activities were downregulated in cells overexpressing WT1, whereas the levels of CDK4, CDK2, and cyclin D1 expression were unchanged. These findings suggest that inhibition of the activity of cyclin/CDK complexes may be involved in mediating the WT1-induced cell cycle block.
Insights
The Wilms tumor-suppressor (WT1) gene product acts as a transcriptional repressor, inhibiting cell cycle progression. WT1
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- The Wilms tumor-suppressor gene (WT1) is crucial for normal urogenital development.
- WT1 encodes a transcriptional repressor protein involved in cell cycle regulation.
Purpose of the Study:
- To investigate the role of WT1 in cell cycle control.
- To elucidate the mechanism by which WT1 inhibits cell cycle progression.
Main Methods:
- Microinjection of WT1 cDNA into quiescent and G1-phase cells.
- Analysis of cell cycle progression following WT1 introduction.
- Assessing the impact of WT1 on cyclin/CDK complex activity and expression.
Main Results:
- WT1 expression blocked serum-induced cell cycle entry into S phase.
- WT1's inhibitory activity was modulated by an alternatively spliced region.
- Overexpression of cyclin E/CDK2 or cyclin D1/CDK4 abrogated WT1's inhibitory effect.
- WT1 overexpression downregulated CDK4- and CDK2-associated kinase activities without altering protein levels.
Conclusions:
- WT1 acts as a cell cycle inhibitor by downregulating cyclin/CDK complex activity.
- Alternative splicing of WT1 influences its cell cycle regulatory function.
- WT1's mechanism involves the inhibition of key cell cycle kinases, suggesting a role in cell cycle checkpoints.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
The Cell Cycle Control System
Inhibition of Cdk Activity
Inhibition of CDK Activity
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...